Clinical Trials Browser

NETWORK × ixazomib × Plasma cell × Clear all

NCT03683277 2025-02-19

IFM2014-01

Phase 2 Terminated

Multiple Myeloma, Recurrence, Genetic Diseases, Inborn

NCT03732703 2025-02-14

MyDRUG

Phase 1/2 Completed

Multiple Myeloma